Letters to the Editor
Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional study
A. Lohse1, M. Bossert2, A.-M. Bozgan3, A. Charpentier4, C. Guillochon5, C. Bourgoin6, J.-C. Balblanc7, T. Conrozier8
- Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
- Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
- Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
- Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
- Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
- Clinical Research Unit, Nord Franche-Comté Hospital, Belfort, France.
- Department of Rheumatology, Nord Franche-Comté Hospital, Belfort, France.
- Department of Rheumatology and Clinical Research Unit, Nord Franche-Comté Hospital, Belfort, France. thierry.conrozier@hnfc.fr
CER13973
2020 Vol.38, N°6
PI 1273
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 33253100 [PubMed]
Received: 25/08/2020
Accepted : 19/10/2020
In Press: 22/11/2020
Published: 03/12/2020